Maxcyte:
Harnessing cell-engineering delivery platform to develop small molecules, vaccines, and cell and gene therapies. Platform based on Flow Electroporation™ Technology, with ability to transfect primary cells, stem cells and cell lines with minimal cell disturbance and transfection efficiencies routinely >90% for a variety of cell types.
Sector/industry:
Healthcare/Medical Diagnostics & Research
Characteristics:
Based in...
US - South Atlantic
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Listing
Europe, Public
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy, Gene editing, Gene Therapy
Website:
Address:
22 Firstfield Road
Suite 110
Gaithersburg, MD 20878
United States
Suite 110
Gaithersburg, MD 20878
United States
Company Participants at Solebury Trout Virtual Global Healthcare Conference Series
- Douglas Doerfler, CEO
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Top 10 Holders of MaxCyte, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| River & Mercantile Asset Management LLP | 6.86 | 3,524,840 | 9.47 | Funds | 2020-05-31 |
| Unicorn Asset Management Ltd. | 5.88 | 3,017,857 | 8.11 | Funds | 2020-06-30 |
| Canaccord Genuity Wealth Ltd. | 5.46 | 2,923,543 | 7.85 | Funds | 2020-01-31 |
| BlackRock Investment Management (UK) Ltd. | 5.45 | 2,799,279 | 7.52 | Stakes | 2020-01-21 |
| Legal & General Investment Management Ltd. | 4.99 | 2,562,752 | 6.88 | Stakes | 2020-01-21 |
| Chelverton Asset Management Ltd. | 3.41 | 1,750,000 | 4.70 | Funds | 2019-12-31 |
| Amati Global Investors Ltd. | 3.33 | 1,709,728 | 4.59 | Funds | 2020-06-30 |
| Amati Global Investors Ltd. (Venture Capital) | 1.87 | 957,860 | 2.57 | Funds | 2020-01-31 |
| Octopus Investments Ltd. | 1.21 | 806,419 | 2.17 | Funds | 2019-11-30 |
| CRUX Asset Management Ltd. | 0.34 | 228,820 | 0.61 | Funds | 2019-09-30 |
Top 10 Holders of MaxCyte, Inc. TEMP
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Canaccord Genuity Wealth Ltd. | 20.32 | 1,210,683 | 3.25 | Funds | 2020-01-31 |
| BlackRock Investment Management (UK) Ltd. | 3.68 | 219,041 | 0.59 | Stakes | 2020-01-21 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.